Vardan T. Karamyan
Vardan T. Karamyan
School of Pharmacy, Texas Tech University Health Sciences Center
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Animal models of BMAA neurotoxicity: a critical review
VT Karamyan, RC Speth
Life sciences 82 (5-6), 233-246, 2008
Cannabinoid ester constituents from high-potency Cannabis sativa (Addition/Correction)
SA Ahmed, SA Ross, D Slade, MM Radwan, F Zulfiqar, RR Matsumoto, ...
Journal of natural products 71 (6), 1119, 2008
Evidence that γ-secretase-mediated notch signaling induces neuronal cell death via the nuclear factor-κB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke
TV Arumugam, YL Cheng, Y Choi, YH Choi, S Yang, YK Yun, JS Park, ...
Molecular pharmacology 80 (1), 23-31, 2011
Enzymatic pathways of the brain renin–angiotensin system: unsolved problems and continuing challenges
VT Karamyan, RC Speth
Regulatory peptides 143 (1), 15, 2007
Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death
J Thundyil, SC Tang, E Okun, K Shah, VT Karamyan, YI Li, TM Woodruff, ...
Experimental & translational stroke medicine 2 (1), 1-8, 2010
Opioid receptor agonists reduce brain edema in stroke
L Yang, H Wang, K Shah, VT Karamyan, TJ Abbruscato
Brain research 1383, 307-316, 2011
The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain
RC Speth, VT Karamyan
Heart failure reviews 13 (3), 299-309, 2008
Artificial neural networks (ANNs) and modeling of powder flow
K Kachrimanis, V Karamyan, S Malamataris
International journal of pharmaceutics 250 (1), 13-23, 2003
2-Methoxyestradiol binding of GPR30 down-regulates angiotensin AT1 receptor
S Koganti, R Snyder, U Gumaste, VT Karamyan, T Thekkumkara
European journal of pharmacology 723, 131-140, 2014
Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome
CS Mizuno, AG Chittiboyina, FH Shah, A Patny, TW Kurtz, ...
Journal of medicinal chemistry 53 (3), 1076-1085, 2010
Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia
L Yang, K Shah, H Wang, VT Karamyan, TJ Abbruscato
Journal of Pharmacology and Experimental Therapeutics 339 (2), 499-508, 2011
Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain
VT Karamyan, RC Speth
Brain research 1143, 83-91, 2007
Functional up‐regulation of endopeptidase neurolysin during post‐acute and early recovery phases of experimental stroke in mouse brain
M Rashid, NJ Wangler, L Yang, K Shah, TV Arumugam, TJ Abbruscato, ...
Journal of neurochemistry 129 (1), 179-189, 2014
Distribution of the non-AT1, non-AT2 angiotensin-binding site in the rat brain: preliminary characterization
VT Karamyan, RC Speth
Neuroendocrinology 88 (4), 256-265, 2008
Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4. 24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site
NJ Wangler, KL Santos, I Schadock, FK Hagen, E Escher, M Bader, ...
Journal of Biological Chemistry 287 (1), 114-122, 2012
Pivotal role for beta-1 integrin in neurovascular remodelling after ischemic stroke
JD Lathia, S Chigurupati, J Thundyil, PK Selvaraj, MR Mughal, ...
Experimental Neurology 221 (1), 107-114, 2010
Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis
RJ Kokje, WL Wilson, TE Brown, VT Karamyan, JW Wright, RC Speth
Hypertension 49 (6), 1328-1335, 2007
In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment
L Yang, MR Islam, VT Karamyan, TJ Abbruscato
Brain research 1609, 1-11, 2015
Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
A Al Shoyaib, SR Archie, VT Karamyan
Pharmaceutical research 37 (1), 1-17, 2020
Association of the novel non-AT1, non-AT2 angiotensin binding site with neuronal cell death
M Rashid, TV Arumugam, VT Karamyan
Journal of Pharmacology and Experimental Therapeutics 335 (3), 754-761, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20